RxDoctor Payments Data

Jill Swinning

Adult Health · Traverse City, MINPI 1902161128

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 61.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $3,366 and has fallen 75.9% since, to $813 in 2025. Among adult health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,148in general payments, 2019–2025

Across 92 payments — averaging $110.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$6K
  • Medtronic$3K
  • Abbott$263
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$162
  • Biosense Webster, Inc.$62
  • Johnson & Johnson$37
  • plus $14 from 1 others

What the payments were for

  • Consulting fees$4,60945%
  • Speaking & faculty fees$9009%
  • Travel & lodging$1,85618%
  • Food & beverage$2,64326%
  • Education$1401%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,148 in reported general payments places this provider in the 95th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$22,802
Medicare patients
242
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$101,372
XareltoRivaroxaban42$47,191
Flecainide Acetate58$3,039
Metoprolol Succinate58$1,440
Amiodarone Hcl42$512
SotalolSotalol Hcl18$383
Pantoprazole Sodium29$378
Diltiazem 24hr Er (Cd)Diltiazem Hcl16$307
Losartan Potassium17$149
Atorvastatin Calcium11$123
Carvedilol14$117
Metoprolol Tartrate30$96

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$37$47,19142 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 527 adult health providers in Michigan.

Other adult health in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →